Three seats. One question.

Clinical data is captured in one place, analyzed in another, and sold against in a third. Most people spend a career in one of those seats. Sextant & Rule was built by someone who has worked in all three, and kept meeting the same unanswered question in each.

The question

Selling into clinical development means working with incomplete information. Your win rate is strong when you engage early and poor when you arrive after scope is set. What you can't see is which programs are between studies right now, while the next protocol is being written.

Most tools describe the market and hand the judgment back to you: pull a list, apply someone else's filters, start calling. It is a definition problem. What makes a program real for your business is specific to your business, and it is almost never a field in someone else's database.

How the answer got built

Not from a product roadmap. From twenty-five years in sales, strategy and data systems, fifteen of them in clinical development and its data.

2000 – 2004

Planning under uncertainty

United States Marine Corps · CBRN Specialist, NCO

One habit carried straight into commercial work: state what is known, what is assumed and what is unknown, separately. Every reading here is written that way.

2010 – 2015

From data structure to clinical data

Enterprise software, then electronic data capture

Software sales where data decided where a sales team spent its week. Then clinical, at an EDC vendor: what trial data exists, what is standardized, and what never leaves the sponsor.

2015 – 2025

A decade inside global CROs

Commercial intelligence, then account development

Built and ran the sales intelligence function for one of the largest CROs in the world, then added prescription and claims data through an acquisition. Development and commercial data are two ends of one roadmap. Five years leading regional account development followed.

2025 – now

Back on the front line

Early development services and international clinical supply

Discovery through Phase I with emerging biotechs, then international clinical logistics. Still carrying a number, still needing the answer. Sextant was built because nothing on the market provided it.

Why this combination matters

The dataKnowing what actually exists

Fifteen years across EDC, clinical trial data and commercial pharmaceutical data: what is reliable, and what only looks it.

The analysisIntelligence, not dashboards

Producing something a sales leader will act on Monday morning is a different craft from producing a report.

The saleStill carrying a number

Business development today, not a decade ago. Every output here is designed by someone who has to use it.

The definition work is never delegated.

Your market definition is built directly with the people who sell it.

Start a conversation See what we deliver